Prealbumin is associated with visceral fat mass in patients receiving hemodialysis

Journal of Renal Nutrition

Volumn 23, Issue 6, 2013, Pages 406-410

  Molfino, Alessio ^a,b   Heymsfield, Steven B ^c   Zhu, Fansan ^d   Kotanko, Peter ^d   Levin, Nathan W ^d   Dwyer, Tjien ^a   Kaysen, George A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PLASMA RETINOL BINDING PROTEIN; PREALBUMIN; RBP4 PROTEIN, HUMAN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGY; RENAL REPLACEMENT THERAPY; SKELETAL MUSCLE; VERY ELDERLY;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; FEMALE; HUMANS; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PREALBUMIN; RENAL DIALYSIS; RETINOL-BINDING PROTEINS, PLASMA; SERUM ALBUMIN;

EID: 84886258488     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.02.007     Document Type: Article

References (32)

1. Desai A.A., Nissenson A., Chertow G.M., et al. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int 2009, 13:347-359.
2. Chertow G.M., Goldstein-Fuchs D.J., Lazarus J.M., et al. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int 2005, 68:2794-2800.
3. Muscaritoli M., Molfino A., Bollea M.R., et al. Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care 2009, 12:378-383.
4. Herselman M., Esau N., Kruger J.M., et al. Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition 2010, 26:10-32.
5. Sengul S., Arat Z., Ozdemir F.N. Renal amyloidosis is associated with increased mortality in hemodialysis patients. Artif Organs 2004, 28:846-852.
6. Owen W.F., Chertow G.M., Lazarus J.M., et al. Dose of hemodialysis and survival: differences by race and sex. JAMA 1998, 280:1764-1768.
7. Rambod M., Kovesdy C.P., Bross R., et al. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008, 88:1485-1494.
8. Chertow G.M., Ackert K., Lew N.L., et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int 2000, 58:2512-2517.
9. Dalrymple L.S., Johansen K.L., Chertow G.M., et al. Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study. J Ren Nutr 2013, 23:91-97.
10. Goldwasser P., Feldman J.G., Barth R.H. Serum prealbumin is higher in peritoneal dialysis than in hemodialysis: a meta-analysis. Kidney Int 2002, 62:276-281.
11. Hyung S.J., Deroo S., Robinson C.V. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex. ACS Chem Biol 2010, 5:1137-1146.
12. Yang Q., Graham T.E., Mody N., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
13. Ost A., Danielsson A., Lidén M., et al. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007, 21:3696-3704.
14. Kovacs P., Geyer M., Berndt J., et al. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007, 56:3095-3100.
15. Graham T.E., Yang Q., Blüher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563.
16. Henze A., Frey S.K., Raila J., et al. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 2008, 57:3323-3326.
17. Cano N.J. Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients. Clin Chem Lab Med 2002, 40:1313-1319.
18. Ziegelmeier M., Bachmann A., Seeger J., et al. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 2007, 30:2588-2592.
19. Axelsson J., O'Byrne S.M., Blaner W.S., et al. Serum retinol-binding protein concentration and its association with components of the uremic metabolic syndrome in nondiabetic patients with chronic kidney disease stage 5. Am J Nephrol 2009, 29:447-453.
20. Mody N., Graham T.E., Tsuji Y., et al. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab 2008, 294:E785-E793.
21. Lee R.C., Wang Z., Heo M., et al. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 2000, 72:796-803.
22. Beckman Instructions 015-248545-F. Brea, CA: Beckam Instruments, Inc; November1994.
23. Canaud B., Leblanc M., Garred L.J., et al. Protein catabolic rate over lean body mass ratio: a more rational approach to normalize the protein catabolic rate in dialysis patients. Am J Kidney Dis 1997, 30:672-679.
24. Kaysen G.A., Dubin J.A., Müller H.G., et al. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 2004, 65:1408-1415. HEMO Study Group NIDDK.
25. Bartalena L., Farsetti A., Flink I.L., et al. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol 1992, 6:935-942.
26. Lilly M.P., Lynch J.R., Wish J.B., et al. Prevalence of arteriovenous fistulas in incident hemodialysis patients: correlation with patient factors that may be associated with maturation failure. Am J Kidney Dis 2012, 59:541-549.
27. Lee T., Ullah A., Allon M., et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol 2011, 6:575-581.
28. Lin Y.C., Lin Y.C., Chen T.W., et al. Abnormal thyroid function predicts mortality in patients receiving long-term peritoneal dialysis: a case-controlled longitudinal study. J Chin Med Assoc 2012, 75:54-59.
29. Das R.R. Zinc and vitamin A for prevention of upper respiratory tract infection in children. Br J Nutr 2012, 108:1722.
30. Ishimura E., Okuno S., Tsuboniwa N., et al. Relationship between fat mass and serum high-sensitivity C-reactive protein levels in prevalent hemodialysis patients. Nephron Clin Pract 2011, 119:c283-c288.
31. Kaysen G.A., Kotanko P., Zhu F., et al. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr 2009, 19:357-364.
32. Kucirka L.M., Grams M.E., Lessler J., et al. Association of race and age with survival among patients undergoing dialysis. JAMA 2011, 306:620-626.